Logo image of NSPR

INSPIREMD INC (NSPR) Stock Fundamental Analysis

NASDAQ:NSPR - Nasdaq - US45779A8466 - Common Stock - Currency: USD

2.48  -0.02 (-0.8%)

Fundamental Rating

3

Overall NSPR gets a fundamental rating of 3 out of 10. We evaluated NSPR against 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of NSPR is average, but there are quite some concerns on its profitability. NSPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NSPR has reported negative net income.
In the past year NSPR has reported a negative cash flow from operations.
In the past 5 years NSPR always reported negative net income.
In the past 5 years NSPR always reported negative operating cash flow.
NSPR Yearly Net Income VS EBIT VS OCF VS FCFNSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -93.45%, NSPR is not doing good in the industry: 78.61% of the companies in the same industry are doing better.
The Return On Equity of NSPR (-127.50%) is worse than 67.91% of its industry peers.
Industry RankSector Rank
ROA -93.45%
ROE -127.5%
ROIC N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
NSPR Yearly ROA, ROE, ROICNSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600 800

1.3 Margins

The Gross Margin of NSPR (21.43%) is worse than 79.68% of its industry peers.
In the last couple of years the Gross Margin of NSPR has remained more or less at the same level.
NSPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
NSPR Yearly Profit, Operating, Gross MarginsNSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

6

2. Health

2.1 Basic Checks

NSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NSPR has more shares outstanding
Compared to 5 years ago, NSPR has more shares outstanding
NSPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NSPR Yearly Shares OutstandingNSPR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NSPR Yearly Total Debt VS Total AssetsNSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -7.38, we must say that NSPR is in the distress zone and has some risk of bankruptcy.
NSPR has a Altman-Z score of -7.38. This is in the lower half of the industry: NSPR underperforms 74.33% of its industry peers.
There is no outstanding debt for NSPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.38
ROIC/WACCN/A
WACC9.07%
NSPR Yearly LT Debt VS Equity VS FCFNSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 4.36 indicates that NSPR has no problem at all paying its short term obligations.
The Current ratio of NSPR (4.36) is better than 68.98% of its industry peers.
A Quick Ratio of 3.98 indicates that NSPR has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.98, NSPR is doing good in the industry, outperforming 71.66% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.36
Quick Ratio 3.98
NSPR Yearly Current Assets VS Current LiabilitesNSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for NSPR have decreased strongly by -12.16% in the last year.
The Revenue has grown by 12.96% in the past year. This is quite good.
NSPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.51% yearly.
EPS 1Y (TTM)-12.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)12.96%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%2.24%

3.2 Future

Based on estimates for the next years, NSPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.21% on average per year.
Based on estimates for the next years, NSPR will show a very strong growth in Revenue. The Revenue will grow by 79.81% on average per year.
EPS Next Y-31.42%
EPS Next 2Y-9.09%
EPS Next 3Y13.21%
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2Y49.34%
Revenue Next 3Y79.81%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NSPR Yearly Revenue VS EstimatesNSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
NSPR Yearly EPS VS EstimatesNSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1M -2M -3M -4M -5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NSPR. In the last year negative earnings were reported.
Also next year NSPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NSPR Price Earnings VS Forward Price EarningsNSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NSPR Per share dataNSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as NSPR's earnings are expected to grow with 13.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.09%
EPS Next 3Y13.21%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NSPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INSPIREMD INC

NASDAQ:NSPR (8/14/2025, 1:09:54 PM)

2.48

-0.02 (-0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners35.25%
Inst Owner Change0.04%
Ins Owners19.04%
Ins Owner Change0.6%
Market Cap75.99M
Analysts82.5
Price Target4.59 (85.08%)
Short Float %1.94%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.68%
Min EPS beat(2)-7.84%
Max EPS beat(2)4.47%
EPS beat(4)2
Avg EPS beat(4)1.17%
Min EPS beat(4)-13.52%
Max EPS beat(4)21.57%
EPS beat(8)5
Avg EPS beat(8)1.71%
EPS beat(12)9
Avg EPS beat(12)9.18%
EPS beat(16)13
Avg EPS beat(16)14.92%
Revenue beat(2)2
Avg Revenue beat(2)4.28%
Min Revenue beat(2)3.38%
Max Revenue beat(2)5.18%
Revenue beat(4)3
Avg Revenue beat(4)2.13%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)5.18%
Revenue beat(8)7
Avg Revenue beat(8)3.63%
Revenue beat(12)11
Avg Revenue beat(12)6.39%
Revenue beat(16)12
Avg Revenue beat(16)2.72%
PT rev (1m)0%
PT rev (3m)-5.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.81
P/FCF N/A
P/OCF N/A
P/B 2.68
P/tB 2.68
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)-0.93
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS0.23
BVpS0.93
TBVpS0.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -93.45%
ROE -127.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.43%
FCFM N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
F-Score3
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 506.82%
Cap/Sales 22.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.36
Quick Ratio 3.98
Altman-Z -7.38
F-Score3
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)304.1%
Cap/Depr(5y)236.96%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
EPS Next Y-31.42%
EPS Next 2Y-9.09%
EPS Next 3Y13.21%
EPS Next 5YN/A
Revenue 1Y (TTM)12.96%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%2.24%
Revenue Next Year4.48%
Revenue Next 2Y49.34%
Revenue Next 3Y79.81%
Revenue Next 5YN/A
EBIT growth 1Y-55.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-33.31%
EBIT Next 3Y-4.97%
EBIT Next 5YN/A
FCF growth 1Y-62.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.64%
OCF growth 3YN/A
OCF growth 5YN/A